Skip to main content

CCTG at 2025 ASCO Annual Meeting

CCTG at 2025 ASCO Annual Meeting

The ASCO 2025 Annual Meeting, is fast approaching and will be held from May 30 to June 3 in Chicago, Illinois -- This year the theme is of "Driving Knowledge to Action: Building a Better Future". This meeting will feature many CCTG trials and research so please see the list below to ensure you do not miss the oral presentations or poster presentations, showcasing the latest in CCTG research and clinical trial results.

 

BREAST

CCTG IND.241

IND.241: A Canadian Cancer Trials Group liquid-biopsy informed platform trial to evaluate treatment in CDK4/6-inhibitor resistant ER+/HER2- metastatic breast.

Abstract #:        TPS1121

Session Type:  Poster Session

Session Title:  Breast Cancer – Metastatic

Track:                  Breast Cancer

Subtrack:           HER-2-Positive

Citation:            

Authors:            David Cescon, Moira Rushton, Nathalie LeVasseur, Michelle Nadler, Daniel Rayson, Brooke Wilson, Sara Taylor, Rossanna Pezo, Arif Ali Awan, Vikaash Kumar, Jen Melvin, John Hilton, Stephen Chia, Philippe Bedard, Spencer Finn, Wei Tu, Courtney Coschi, Philippe Jamme, Elia Aguado-Fraile, Lesley Seymour

Abstract link:   https://meetings.asco.org/abstracts-presentations/252192

 

CCTG MA.37/ ABCSG-42/AFT-05/BIG-14-13/PrE0109 

Treatment-related neutropenia as a predictor of response to adjuvant palbociclib in the PALLAS trial (ABCSG-42/AFT-05/BIG-14-13/PrE0109).

Abstract #:        526

Session Type:  Poster Session

Session Title:  Breast Cancer—Local/Regional/Adjuvant

Track:                  Breast Cancer

Subtrack:           Adjuvant Therapy

Citation:            

Authors:           Kristina Fanucci, Amylou Dueck, Erica Mayer, Miguel Martin, Tufia Haddad, Nicholas Zdenkowski, Guenther Steger, Yelena Novik, Jennifer Suga, Julie Lemieux, Tiffany Traina, Sibylle Loibl, Meritxell Bellet, Antonio Wolff, Jana Machacek-Link, Eric Gauthier, Sara Scovil, Dominik Hlauschek, Michael Gnant, Angela DeMichele

Abstract link: https://meetings.asco.org/abstracts-presentations/244429

CCTG MA.40 

A double-blind placebo controlled randomized phase III trial of fulvestrant and ipatasertib as treatment for advanced HER-2 negative and estrogen receptor positive (ER+) breast cancer following progression on first line CDK 4/6 inhibitor and aromatase inhibitor: The CCTG/BCT MA.40/FINER study (NCT04650581).

Abstract #:        LBA1005

Session Type:  Oral Abstract Session

Session Title:  Breast Cancer—Metastatic

Track:                  Breast Cancer

Subtrack:           Hormone Receptor-Positive

Citation:            

Authors:           Stephen Chia, Andrew Redfern, Jean-Pierre Ayoub, Haji Chalchal, Daniel Rayson, Moira Rushton, Christine Desbiens, Dhanusha Sabanathan, Jacques Raphael, Angela Chan, Jessica Singh, Christine Simmons, Nicholas Zdenkowski, Sheridan Wilson, Danielle Rodin, David Cescon, Frauke Schimmoller, Lisa Gallinaro, Bingshu Chen, Wendy Parulekar

Abstract link: https://meetings.asco.org/abstracts-presentations/244383


 

 

CCTG MAC.13/BIG 2-06/NCCTG N063D

Long-term outcomes of patients with HER2-positive invasive lobular carcinoma in the ALTTO trial (BIG 2-06/NCCTG N063D [Alliance])

Abstract #:        542

Session Type:  Poster Session

Session Title:  Breast Cancer – Local/Regional/Adjuvant

Track:                  Breast Cancer

Subtrack:           Adjuvant Therapy

Citation:            

Authors:           Guilherme Nader Marta, Lieveke Ameye, Giuseppe Viale, Diogo Martins-Branco, Marianne Paesmans, Philippe Aftimos, Christine Desmedt, Anup Choudhury, Antonio Wolff, Ian Krop, Martine Piccart-Gebhart, Evandro de Azambuja

Abstract link:  https://meetings.asco.org/abstracts-presentations/244439

CCTG MAC.20/Alliance A011401

Association of lifestyle factors and pathological characteristics in patients with early breast cancer and overweight/obesity: Results from the Breast Cancer Weight Loss (BWEL) trial.

Abstract #:        561

Session Type:  Poster Session

Session Title:  Breast Cancer – Local/Regional/Adjuvant

Track:                  Breast Cancer

Subtrack:           Biologic Correlates

Citation:            

Authors:           Caterina Sposetti, Karla Ballman, Linda McCall, Pamela Goodwin, Anna Weiss, Cynthia Thomson, Olwen Hahn, Dawn Hershman, Electra Paskett, Lori Minasian, Linda Nebeling, Erica Mayer, Judith Hopkins, Vanessa Bernstein, Vered Stearns, Julia White, Eric Winer, Ann Partridge, Lisa Carey, Jennifer Ligibel

Abstract link: https://meetings.asco.org/abstracts-presentations/245927

 

CCTG MAC.20/Alliance A011401 

Intervention adherence, engagement and tool utilization in the breast cancer weight loss (BWEL) trial by race and ethnicity (Alliance A011401).

Abstract #:        1586

Session Type:  Poster Session

Session Title:  Care Delivery/Models of Care

Track:                  Care Delivery and Quality Care

Subtrack:           Disparities in Care

Citation:            

Authors:           Ashley Odai-Afotey, Linda McCall, Karla Ballman, Chao Cao, Pamela Goodwin, Vanessa Bernstein, Linda Delahanty, Dawn Hershman, Judith Hopkins, Erica Mayer, Electra Paskett, Patricia Spears, Vered Stearns, Anna Weiss, Julia White, Thomas Wadden, Eric Winer, Lisa Carey, Ann Partridge, Jennifer Ligibel

Abstract link:  https://meetings.asco.org/abstracts-presentations/245405

 


 

 

CCTG MAC.28/NRG BR007 

NRG-BR007: A phase III trial evaluating de-escalation of breast radiation (DEBRA) following breast-conserving surgery of stage 1, HR+, HER2-, RS ≤18 breast cancer.

Abstract #:        TPS625

Session Type:  Poster Session

Session Title:  Breast Cancer—Local/Regional/Adjuvant

Track:                  Breast Cancer

Subtrack:           Local-Regional Therapy

Citation:            

Authors:           Julia White, Reena Cecchini, Eleanor Harris, Eleftherios Mamounas, Jose Bazan, Daniel Stover, Patricia Ganz, Reshma Jagsi, Stewart Anderson, Carmen Bergom, Valérie Théberge, Mahmoud El-Tamer, Richard Zellars, Dean Shumway, Guang-Pei Chen, Thomas Julian, Norman Wolmark

Abstract link: https://meetings.asco.org/abstracts-presentations/252167

CCTG MAC.30/NRG BR009 

A phase III trial evaluating addition of adjuvant chemotherapy to ovarian function suppression + endocrine therapy in premenopausal women with pN0-1, HR+/HER2- breast cancer (BC) and oncotype recurrence score (RS) ≤25 (OFSET): NRG-BR009.

Abstract #:        TPS615

Session Type:  Poster Session

Session Title:  Breast Cancer—Local/Regional/Adjuvant

Track:                  Breast Cancer

Subtrack:           Adjuvant Therapy

Citation:            

Authors:           Eleftherios Mamounas, Gong Tang, Shannon Puhalla, Sandra Swain, Patricia Ganz, Norah Henry, Reena Cecchini, Sonya Reid, Priya Rastogi, Charles Geyer Jr., Julia White, Amy Clark, Tufia Haddad, Gregory Vidal, Norman Wolmark

Abstract link: https://meetings.asco.org/abstracts-presentations/252168

GASTROINTESTINAL

CCTG CO.21

A randomized phase III trial of the impact of a structured exercise program on disease-free survival (DFS) in stage 3 or high-risk stage 2 colon cancer: Canadian Cancer Trials Group (CCTG) CO.21 (CHALLENGE).

Abstract #:        LBA3510

Session Type:  Clinical Science Symposium

Session Title:  Adjunctive Therapies in Colon Cancer: As Good as a Drug?

Track:                  Gastrointestinal Cancer—Colorectal and Anal

Subtrack:           Colorectal Cancer–Local-Regional Disease

Citation:            

Authors:            Christopher Booth, Janette Vardy, Christopher O'Callaghan, Sharlene Gill, Christine Friedenreich, Rebecca Wong, Haryana Dhillon, Victoria Coyle, Neil Chua, Derek Jonker, Philip Beale, Kamal Haider, Patricia Tang, Tony Bonaventura, Ralph Wong, Howard Lim, Matthew Burge, Patti O'Brien, Dongsheng Tu, Kerry Courneya

Abstract link:   https://meetings.asco.org/abstracts-presentations/244420

 


 

 

CCTG CO.29/AGITG CTDNA-08

ctDNA-guided adjuvant chemotherapy escalation in stage III colon cancer: Primary analysis of the ctDNA-positive cohort from the randomized AGITG dynamic-III trial (intergroup study of AGITG and CCTG).

Abstract #:        3503

Session Type:  Oral Abstract Session

Session Title:  Gastrointestinal Cancer—Colorectal and Anal

Track:                  Gastrointestinal Cancer— Colorectal and Anal 

Subtrack:           Colorectal Cancer–Local-Regional Disease

Citation:            

Authors:            Jeanne Tie, Yuxuan Wang, Jonathan Loree, Joshua Cohen, David Espinosa, Rachel Wong, Timothy Price, Niall Tebbutt, Margaret Lee, Matthew Burge, Samuel Harris, Belinda Lee, James Lynam, Christopher O'Callaghan, Daniel Breadner, Chetan Bettegowda, Nickolas Papadopoulos, Kenneth Kinzler, Bert Vogelstein, Peter Gibbs

Abstract link:   https://meetings.asco.org/abstracts-presentations/244719

 

CCTG CRC.5//CALGB/SWOG 80405

Long non-coding RNA (lncRNA) SNHG11 as a prognostic and predictive biomarker in metastatic colorectal cancer (mCRC): Insights from CALGB (Alliance)/SWOG 80405.

Abstract #:        3128

Session Type:  Poster

Session Title:  Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Track:                  Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Subtrack:           Tissue-Based Biomarkers

Citation:            

Authors:            Michela Bartolini, Francesca Battaglin, Joshua Millstein, Fang-Shu Ou, Shivani Soni, Pooja Mittal, Sandra Algaze, Karam Ashouri, Lesly Torres-Gonzalez, Unnati Shah, Priya Jayachandran, Wu Zhang, Alan Venook, Federico Innocenti, Alberto Puccini, Heinz-Josef Lenz

Abstract link:   https://meetings.asco.org/abstracts-presentations/244175

 

CCTG CRC.5/CALGB/SWOG 80405

Small nucleolar RNAs (snoRNAs) expression and effects on patient (pt) outcomes in metastatic colorectal cancer (mCRC): Data from CALGB (Alliance)/SWOG 80405.

Abstract #:        3145

Session Type:  Poster

Session Title:  Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Track:                  Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Subtrack:           Tissue-Based Biomarkers

Citation:            

Authors:            Francesca Battaglin, Joshua Millstein, Michela Bartolini, Karam Ashouri, Shivani Soni, Sandra Algaze, Pooja Mittal, Lesly Torres-Gonzalez, Priya Jayachandran, Unnati Shah, Wu Zhang, Federico Innocenti, Fang-Shu Ou, Alan Venook, Heinz-Josef Lenz

Abstract link:   https://meetings.asco.org/abstracts-presentations/244176

 


 

 

CCTG CRC.6/CALGB/SWOG 80702

Association between empirical dietary inflammatory pattern (EDIP) and survival in patients with stage III colon cancer: Findings from CALGB/SWOG 80702 (Alliance).

Abstract #:        LBA3509

Session Type:  Clinical Science Symposium

Session Title:  Adjunctive Therapies in Colon Cancer: As Good as a Drug?

Track:                  Gastrointestinal Cancer—Colorectal and Anal

Subtrack:           Epidemiology/Outcomes

Citation:            

Authors:           Sara Char, Qian Shi, Tyler Zemla, Chao Ma, En Cheng, Priya Kumthekar, Katherine Guthrie, Felix Couture, J. Kuebler, Pankaj Kumar, Benjamin Tan, Smitha Krishnamurthi, Brian Wolpin, Francois Geoffroy, Fred Tabung, Anthony Shields, Eileen O'Reilly, Jeffrey Meyerhardt, Chen Yuan, Kimmie Ng

Abstract link:  https://meetings.asco.org/abstracts-presentations/244419

 

CCTG CRC.6/CALGB/SWOG 80702

Sex differences in chemotherapy completion and adverse events among patients with colon cancer (CALGB/SWOG 80702) (Alliance).

Abstract #:        3624

Session Type:  Poster Session

Session Title:   Gastrointestinal Cancer—Colorectal and Anal

Track:                  Gastrointestinal Cancer—Colorectal and Anal

Subtrack:           Epidemiology/Outcomes

Citation:            

Authors:            En Cheng, Qian Shi, Anthony Shields, Chaoyuan Kuang, Ardaman Shergill, Chao Ma, Katherine Guthrie, Felix Couture, J. Kuebler, Pankaj Kumar, Benjamin Tan, Smitha Krishnamurthi, Kimmie Ng, Eileen O'Reilly, Justin Brown, Philip Philip, Jeffrey Meyerhardt

Abstract link:  https://meetings.asco.org/abstracts-presentations/244843

 

CCTG CRC.10/NRG GI008

Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-NORTH AMERICA): NRG-GI008.

Abstract #:        TPS3644

Session Type:  Poster Session

Session Title:  Gastrointestinal Cancer—Colorectal and Anal

Track:                  Gastrointestinal Cancer—Colorectal and Anal

Subtrack:           Colorectal Cancer–Local-Regional Disease

Citation:            

Authors:            Arvind Dasari, Guan Yu, Scott Kopetz, Shannon Puhalla, Peter Lucas, Ibrahim Halil Sahin, Dustin Deming, Philip Philip, Theodore Hong, Yesenia Rojas-Khalil, Jonathan Loree, Norman Wolmark, Greg Yothers, Thomas George, Christopher Lieu

Abstract link:  https://meetings.asco.org/abstracts-presentations/252298

 


 

 

CCTG NE.2/AGITG AG0219NET

Australasian Gastro-Intestinal Trials Group (AGITG) STOPNET: A randomized study of cessation of somatostatin analogues (SSA) after peptide receptor radionuclide therapy (PRRT) in mid, hind-gut, and pancreatic neuroendocrine tumours.

Abstract #:        TPS4224

Session Type:  Poster Session

Session Title:  Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track:                  Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Subtrack:           Neuroendocrine/Carcinoid

Citation:            

Authors:            Matthew Burge, David Wyld, David Pattison, Sandra Bahamad, Sarah Hayes, Julia Kuszewski, Lorraine Chantrill, Timothy Price, Hui-Li Wong, David Chan, Piyush Grover, Michael Michael, Derrick Siu, Christine Bishop, Daniel Barker, Rachel Goodwin, Christopher O'Callaghan, Jonathan Loree, W Mak

Abstract link:   https://meetings.asco.org/abstracts-presentations/252346

 

CCTG PA.7

Concurrent mutations in DNA damage repair genes BRCA1, POLE, ATM and FANCA to predict overall and progression-free survival for patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) treated with chemotherapy in combination with dual checkpoint inhibition in the CCTG randomized PA.7 trial.

Abstract #:        4178

Session Type:  Poster Session

Session Title:  Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track:                  Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Subtrack:           Pancreatic Cancer - Advanced/Metastatic Disease

Citation:            

Authors:            Daniel Renouf, James Topham, Jonathan Loree, Dongsheng Tu, David Schaeffer, Jennifer Knox, Petr Kavan, Derek  Jonker, Stephen Welch, Felix Couture, Frederic Lemay, Mustapha Tehfe, Mohammed Harb, Nathalie Aucoin, Yoo-Joung Ko, Patricia Tang, Pan Du, Shidong Jia, Sharlene Gill, Christopher O'Callaghan

Abstract link:   https://meetings.asco.org/abstracts-presentations/249858

 

GENITOURINARY 

CCTG IND.234C

Substudy C of the Canadian cancer trials group (CCTG) IND.234: PC_BETS (Prostate Cancer Biomarker Enrichment and Treatment Selection)—A phase II study of darolutamide (DARO) selected by androgen-receptor (AR) circulating tumor DNA (ctDNA) in patients (PTS) with metastatic castration-resistant prostate cancer (mCRPC) after prior AR pathway inhibitors (ARPIs).

Abstract #:        5056

Session Type:  Poster Session

Session Title:  Genitourinary Cancer—Prostate, Testicular, and Penile

Track:                  Genitourinary Cancer—Prostate, Testicular, and Penile

Subtrack:           Prostate Cancer– Advanced/Castrate-Resistant

Citation:            

Authors:            Michael Ong, Kim Chi, Sebastien Hotte, Eric Winquist, Fred Saad, Cristiano Ferrario, Robyn Macfarlane, Michael Kolinsky, Aaron Hansen, Muhammad Salim, Christian Kollmannsberger, Aly-Khan Lalani, Lesley Seymour, Som Mukherjee, Edmond Kwan, Max Sherry, Dongsheng Tu, Mariam Jafri, Alexander Wyatt, Wei Tu

Abstract link:   https://meetings.asco.org/abstracts-presentations/246341

 

CCTG IND.234F

Substudy F of the Canadian Cancer Trials Group (CCTG) IND.234: PC_BETS (Prostate Cancer Biomarker Enrichment and Treatment Selection)—A biomarker-selected phase II study of durvalumab and tremelilumab (DT) in patients (pts) with previously treated metastatic castration-resistant prostate cancer (mCRPC) resistant to AR pathway inhibitors (ARPI).

Abstract #:        5057

Session Type:  Poster Session

Session Title:  Genitourinary Cancer—Prostate, Testicular, and Penile

Track:                  Genitourinary Cancer—Prostate, Testicular, and Penile

Subtrack:           Prostate Cancer– Advanced/Castrate-Resistant

Citation:            

Authors:            Sebastien Hotte, Daniel Khalaf, D. S. Ernst, Cristiano Ferrario, Michael Ong, Michael Kolinsky, Muhammad Salim, Lucia Nappi, Som Mukherjee, Eric Winquist, April Rose, Kim Chi, Kylea Potvin, Lesley Seymour, Edmond Kwan, Martin Smoragiewicz, Hamid Ghaedi, Wei Tu, Mariam Jafri, Alexander Wyatt

Abstract link:   https://meetings.asco.org/abstracts-presentations/246342

 

CCTG IND.234G

Substudy G of the Canadian cancer trials group (CCTG) IND.234: PC_BETS (V)—A circulating tumor DNA (ctDNA)–directed phase II study of carboplatin in patients (Pts) with previously treated metastatic castration-resistant prostate cancer (mCRPC).

Abstract #:        5058

Session Type:  Poster Session

Session Title:  Genitourinary Cancer—Prostate, Testicular, and Penile

Track:                  Genitourinary Cancer—Prostate, Testicular, and Penile

Subtrack:           Prostate Cancer– Advanced/Castrate-Resistant

Citation:            

Authors:            April Rose, Sebastien Hotte, Eric Winquist, Robyn Macfarlane, Kim Chi, Michael Kolinsky, Muhammad Salim, Di Maria Jiang, Michael Ong, Cristiano Ferrario, Aly-Khan Lalani, D. S. Ernst, Parvaneh Fallah, Matti Annala, Edmond Kwan, Francisco Vera Badillo, Lesley Seymour, Wei Tu, Alexander Wyatt, Mariam Jafri

Abstract link:   https://meetings.asco.org/abstracts-presentations/246343

 

CCTG IND.234/223

Canadian Cancer Trials Group (CCTG) IND.234/223: PC_BETS (Prostate Cancer Biomarker Enrichment and Treatment Selection)–A molecularly selected cooperative group platform study.

Abstract #:        5066

Session Type:  Poster Session

Session Title:  Genitourinary Cancer—Prostate, Testicular, and Penile

Track:                  Genitourinary Cancer—Prostate, Testicular, and Penile

Subtrack:           Prostate Cancer– Advanced/Castrate-Resistant

Citation:            

Authors:            Alexander Wyatt, Kim Chi, Sebastien Hotte, Cristiano Ferrario, Eric Winquist, Michael Ong, Michael Kolinsky, Robyn Macfarlane, Fred Saad, Aaron Hansen, Aly-Khan Lalani, Daniel Khalaf, April Rose, D. S. Ernst, Christina Canil, James Hutchenreuther, Lesley Seymour, Wei Tu, Mariam Jafri, Hamid Ghaedi

Abstract link:  https://meetings.asco.org/abstracts-presentations/246359

 


 

 

CCTG PR.24

Androgen suppression combined with elective nodal irradiation and dose escalated prostate treatment: A non-inferiority, phase III randomized controlled trial of stereotactic body radiation therapy versus brachytherapy boost in patients with unfavourable risk localized prostate cancer (ASCENDE-SBRT; CCTG PR24; NCT06235697)

Abstract #:        TPS5132

Session Type:  Poster Session

Session Title:  Genitourinary Cancer—Prostate, Testicular, and Penile

Track:                  Genitourinary Cancer—Prostate, Testicular, and Penile

Subtrack:           Prostate Cancer–Local-Regional Disease

Citation:            

Authors:            Andrew Loblaw, Rachel Glicksman, Joelle Helou, Winkle Kwan, Gerard Morton, Tamim Niazi, Melanie Davidson, M. N. Reaume, Alexander Wyatt, Constance Laroche-Lefebvre, Keyue Ding, Wendy Parulekar

Abstract link:  https://meetings.asco.org/abstracts-presentations/253058

 

CCTG PR.25

A randomized phase III trial investigating platinum and taxane chemotherapy in metastatic castration resistant prostate cancer (mCRPC) patients with alterations in DNA damage response (DDR) genes (OPTION-DDR) CCTG-PR-25 NCT06439225.

Abstract #:        TPS5122

Session Type:  Poster Session

Session Title:  Genitourinary Cancer—Prostate, Testicular, and Penile

Track:                  Genitourinary Cancer—Prostate, Testicular, and Penile

Subtrack:           Prostate Cancer– Advanced/Castrate-Resistant

Citation:            

Authors:            Michael Kolinsky, Kim Chi, Sebastien Hotte, Michael Brundage, Michael Ong, David Boren, M. N. Reaume, Alexander Wyatt, Wendy Parulekar, Keyue Ding, Mariam Jafri

Abstract link:  https://meetings.asco.org/abstracts-presentations/252393

 

CCTG PR.26

TRIPLE-SWITCH (SWOG/CCTG-PR26): A randomized phase III clinical trial for the addition of docetaxel to androgen receptor pathway inhibitors in patients with metastatic castration sensitive prostate cancer (mCSPC) and suboptimal PSA response (NCT06592924).

Abstract #:        TPS5129

Session Type:  Poster Session

Session Title:  Genitourinary Cancer—Prostate, Testicular, and Penile

Track:                  Genitourinary Cancer—Prostate, Testicular, and Penile

Subtrack:           Prostate Cancer– Advanced/Hormone-Sensitive

Citation:            

Authors:            Michael Ong, Alexandra Sokolova, Sebastien Hotte, Tanya Dorff, Kim Chi, Alexander Wyatt, Amir Goldkorn, Michael Kolinsky, Michael Brundage, Akunne Ndika, Seth Lerner, Wendy Parulekar, Keyue Ding, Mariam Jafri

Abstract link:  https://meetings.asco.org/abstracts-presentations/252386

 


 

GYNECOLOGIC CANCER

CCTG VU.2

Stratification of vulvar squamous cell carcinoma (VSCC) by HPV and P53 status to guide excision: CCTG VU.2 STRIVE study (NCT06358469).

Abstract #:        TPS5637

Session Type:  Poster Session

Session Title:  Gynecologic Cancer

Track:                  Gynecologic Cancer

Subtrack:           Other Gynecologic Cancer

Citation:            

Authors:            Amy Jamieson, Jessica McAlpine, Lien Hoang, Mark Carey, Mary Kinloch, Eric Leung, Vanessa Samouëlian, Stephen Welch, Iwa Kong, Janice S. Kwon, Heather Tomalty, Dongsheng Tu, Wendy Parulekar

Abstract link:  https://meetings.asco.org/abstracts-presentations/253003            

 

 

HEAD AND NECK CANCER

CCTG HN.13

A phase III randomized controlled trial comparing palliative stereotactic body radiotherapy vs. palliative standard radiotherapy in patients with advanced head and neck cancer (NCT06641791).

Abstract #:        TPS6118

Session Type:  Poster Session

Session Title:  Head and Neck Cancer

Track:                  Head and Neck Cancer

Subtrack:           Local-Regional Disease

Citation:            

Authors:            Ian Poon, Irene Karam, Houda Bahig, Brock Debenham, Adam Mutsaers, Murali Rajaraman, Chiaojung Jillian Tsai, Lee Chin, Madette Galapin, Scott Bratman, Jolie Ringash, Ambika Parmar, Koren Smith, Sarah Radcliffe, Wei Tu, Wendy Parulekar

Abstract link:  https://meetings.asco.org/abstracts-presentations/252904            

 

 

SUPPORTIVE CARE

CCTG SC.29

A randomized phase III study comparing stereotactic body radiotherapy (SBRT) versus conventional palliative radiotherapy (CRT) for participants with painful non-spine bone metastases (NCT06391242).

Abstract #:        TPS12141

Session Type:  Poster Session

Session Title:  Symptom Science and Palliative Care

Track:                  Symptom Science and Palliative Care

Subtrack:           Palliative Care and Symptom Management

Citation:            

Authors:            Arjun Sahgal, Tim Nguyen, Laura Masucci, Kristopher Dennis, Emma Dunne, Anand Swaminath, Isabelle Thibault, Chiaojung Jillian Tsai, Pejman Maralani, Michael Brundage, Marc Kerba, Joel Lefebvre, Wei Tu, Wendy Parulekar

Abstract link:  https://meetings.asco.org/abstracts-presentations/252931            


 

LUNG/THORACIC ONCOLOGY

CCTG BR.36

A biomarker-directed, multi-center phase II/III study of ctDNA molecular response adaptive immuno-chemotherapy in patients with non-small cell lung cancer (BR.36).

Abstract #:        TPS8669

Session Type:  Poster Session

Session Title:  Lung Cancer – Non-Small Cell Metastatic

Track:                  Lung Cancer

Subtrack:           Immunotherapies

Citation:            

Authors:            Valsamo Anagnostou, Sara Moore, Penelope Bradbury, Cheryl Ho, Rosalyn Juergens, Adrian Sacher, Sofia Genta, Lacey Pitre, Michela Febbraro, Julie Brahmer, Egor Avrutin, Pierre-Olivier Gaudreau, Mark Sausen, Samik Upadhaya, Alicia Zhou, Keyue Ding, Janet Dancey

Abstract link: https://meetings.asco.org/abstracts-presentations/252564